Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Monday, July 12, 2010<br />
Congress Sessions cont’d<br />
n Exam<strong>in</strong>ation of Differential T Regulatory<br />
Lymphocyte Responses Follow<strong>in</strong>g Human FIX<br />
Gene Therapy <strong>in</strong> a Novel Mouse Model<br />
Express<strong>in</strong>g Defective Human Factor IX<br />
Compared to Factor IX Knockout Mice<br />
Hu G1 , Monahan P1 , Gui T1 , Velander W2 ,<br />
Stafford D1 1University of North Carol<strong>in</strong>a at Chapel Hill,<br />
U.S.A., 2University of Nebraska-L<strong>in</strong>coln, U.S.A.<br />
n Distribution of von Willebrand Disease (VWD)<br />
Types <strong>in</strong> 197 Families from the French National<br />
Reference Center for VWD (CRMW): Type 1 is<br />
not the most Frequent with<strong>in</strong> “True” VWD<br />
Fress<strong>in</strong>aud E1 , Goudemand J2 , Boisseau P3 ,<br />
Ternisien C3 , Itzhar N1 , Dreyfus M4 1 2 Hopital Anto<strong>in</strong>e Beclere, University Hospital of<br />
Lille, 3University Hospital of Nantes, 4University<br />
Hospital of Bicêtre, France<br />
n The European Network of Rare Bleed<strong>in</strong>g<br />
Disorders (EN-RBD) Project: Results of 3-Years<br />
Analysis<br />
Peyvandi F1 , Menegatti M1 , Palla R1 , Siboni SM1 ,<br />
Halimeh S2 , Pergantou H3 , Celkan T4, Gilmore R5 ,<br />
Mikovic D6 , Benedik-Dolnicar M7 , Giangrande P8 1A. Bianchi Bonomi Hemophilia and Thrombosis<br />
Center, Fondazione IRCCS Ca’ Granda, Ospedale<br />
Maggiore Policl<strong>in</strong>ico, Università degli Studi di<br />
Milano and Luigi Villa Foundation, Milan, Italy,<br />
2MVZ Labor Duisburg GmbH - Duisburg,<br />
Germany, 3Haemophillia Center, Haemostasis<br />
Unit, Agia Sofia Children’s Hospital, Athens,<br />
Greece, 4Department of Pediatric Hematology-<br />
Oncology, Cerrahpasa Medical Faculty of<br />
Istanbul University, Istanbul, Turkey, 5National Centre for Hereditary Coagulation Disorders, St<br />
James's Hospital, Dubl<strong>in</strong>, Ireland, 6Haemostasis Department and Haemophilia Center, Blood<br />
Transfusion Institute of Serbia, Belgrade, Serbia,<br />
7National Haemophilia Center, University<br />
Children’s Hospital, Ljubljana, Slovenia, 8Oxford Haemophilia & Thrombosis Centre, Nuffield<br />
Department of Cl<strong>in</strong>ical Medic<strong>in</strong>e, University of<br />
Oxford, U.K.<br />
n Electronic Bleed<strong>in</strong>g Questionnaire: A Novel<br />
Approach <strong>in</strong> the Diagnosis of Mild Bleed<strong>in</strong>g<br />
Disorders<br />
Hamilton A1 , Scovil S2 , Elbatarny H1 , Othman M1 1Laurentian University- St Lawrence College,<br />
2Biomotion Laboratory, Queen's University,<br />
K<strong>in</strong>gston, ON, Canada<br />
26<br />
n Thromb<strong>in</strong> Generation <strong>in</strong> Patients with a<br />
Bleed<strong>in</strong>g Tendency of Unknown Orig<strong>in</strong><br />
Ay C, Haselböck J, Laczkovics C, Koder S,<br />
Pab<strong>in</strong>ger I<br />
Cl<strong>in</strong>ical Division of Haematology and<br />
Haemostaseology, Department of Medic<strong>in</strong>e I,<br />
Medical University of Vienna, Austria<br />
n Cl<strong>in</strong>ical Bleed<strong>in</strong>g Episodes <strong>in</strong> Women with Rare<br />
Bleed<strong>in</strong>g Disorders: Results from the<br />
European Network of Rare Bleed<strong>in</strong>g Disorders<br />
(EN-RBD) Project<br />
Mikovic D1 , Siboni SM2 , Benedik-Dolnicar M3 ,<br />
Bidl<strong>in</strong>gmaier C4 , Celkan T5 , Gilmore R6 , Pergantou<br />
H7 , Giangrande P8 , Peyvandi F2 1Haemostasis Department and Haemophilia<br />
Center, Blood Transfusion Institute of Serbia,<br />
Belgrade, Serbia, 2A Bianchi Bonomi Hemophilia<br />
and Thrombosis Center, Fondazione IRCCS Ca’<br />
Granda, Ospedale Maggiore Policl<strong>in</strong>ico, Università<br />
degli Studi di Milano and Luigi Villa Foundation,<br />
Milan, Italy, 3National Haemophilia Center,<br />
University Children’s Hospital, Ljubljana, Slovenia,<br />
4Pediatric Hemophilia and Thrombosis Centre, Dr.<br />
von Hauner‘s Children‘s University Hospital,<br />
Munich, Germany, 5Department of Pediatric<br />
Hematology-Oncology, Cerrahpasa Medical<br />
Faculty of Istanbul University, Istanbul, Turkey,<br />
6National Centre for Hereditary Coagulation<br />
Disorders, St James's Hospital, Dubl<strong>in</strong>, Ireland,<br />
7Haemophillia Center, Haemostasis Unit, Agia<br />
Sofia Children’s Hospital, Athens, Greece,<br />
8Oxford Haemophilia & Thrombosis Centre,<br />
Nuffield Department of Cl<strong>in</strong>ical Medic<strong>in</strong>e,<br />
University of Oxford, Oxford, United K<strong>in</strong>gdom<br />
M2.3 – MULTIDISCIPLINARY≤<br />
Importance of Psychosocial Support <strong>in</strong> the<br />
Treatment of People with Bleed<strong>in</strong>g Disorders<br />
and Their Families<br />
Room: Puerto Madero<br />
Chair: Frederica Cassis, Brazil<br />
n How NMO Leaders Can Promote Psychosocial<br />
Services for Their Patients<br />
Ed Kuebler, U.S.A.<br />
n Psychosocial Needs of an Inhibitor Patient<br />
Alison Inder, New Zealand<br />
n Methods of Support for Children & Their<br />
Families<br />
Silv<strong>in</strong>a Grana, Argent<strong>in</strong>a<br />
n Importance of Integrat<strong>in</strong>g Psychosocial<br />
Discipl<strong>in</strong>e <strong>in</strong>to Comprehensive Care<br />
Frederica Cassis, Brazil